Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 9, Pages 4495
Publisher
MDPI AG
Online
2021-04-27
DOI
10.3390/ijms22094495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
- (2021) Joanna Michałowska et al. Nutrients
- NOX-Dependent Signaling Dysregulation in Severe COVID-19: Clues to Effective Treatments
- (2021) Simona Damiano et al. Frontiers in Cellular and Infection Microbiology
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters
- (2021) François Briand et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death
- (2020) François Briand et al. CTS-Clinical and Translational Science
- Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
- (2020) Tatsuo Kanda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid for the treatment of NASH
- (2020) Jordan Hindson Nature Reviews Gastroenterology & Hepatology
- Regulation of ANGPTL8 in liver and adipose tissue by nutritional and hormonal signals and its effect on glucose homeostasis in mice
- (2020) Lu Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects
- (2020) Cara H. Nelson et al. CLINICAL PHARMACOKINETICS
- Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
- (2020) Ze Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
- (2020) Kaku Goto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- No anti-fibrotic effect of selonsertib in NASH
- (2020) Iain Dickson Nature Reviews Gastroenterology & Hepatology
- Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
- (2020) Rima M. Chakaroun et al. Nutrients
- Obeticholic acid for the treatment of nonalcoholic steatohepatitis
- (2020) Raj A. Shah et al. Expert Review of Gastroenterology & Hepatology
- Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression
- (2020) Xiongfeng Pan et al. International Journal of Environmental Research and Public Health
- Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
- (2020) Helen Jarvis et al. PLOS MEDICINE
- Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
- (2020) Yan Q. Chen et al. JOURNAL OF LIPID RESEARCH
- The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
- (2020) Daniela Maria Tanase et al. Journal of Diabetes Research
- Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
- (2020) Maryam Mahjoubin-Tehran et al. Molecular Metabolism
- Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis
- (2020) Le Thi Thanh Thuy et al. Clinical and Molecular Hepatology
- Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming
- (2020) Soung Won Jeong Diabetes & Metabolism Journal
- Hepatocellular carcinoma: old friends and new tricks
- (2020) Eunsun Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan
- (2020) Hirayuki Enomoto et al. JOURNAL OF GASTROENTEROLOGY
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation
- (2019) Ghada Abdelmoemen et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Hepatocellular Carcinoma: From Molecular Basis to Novel Treatment Approaches
- (2019) Hikmet Akkız Canadian Journal of Gastroenterology and Hepatology
- On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity
- (2019) Oleg Kovrov et al. JOURNAL OF LIPID RESEARCH
- Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease
- (2019) X. Wang et al. DIABETES & METABOLISM
- The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
- (2019) Arun J. Sanyal et al. HEPATOLOGY
- LOXL2—A New Target in Antifibrogenic Therapy?
- (2019) Angela Puente et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characterization of Vitamin A Metabolome in Human Livers with and without NAFLD
- (2019) Guo Zhong et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Prognostic profile of patients with non‑viral hepatocellular carcinoma: A comparative study with hepatitis C virus‑related hepatocellular carcinoma using data mining analysis
- (2019) Yu Noda et al. Oncology Letters
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs
- (2019) Min-Woo Lee et al. Journal of Clinical Medicine
- Role of Gut Microbiota in Hepatocarcinogenesis
- (2019) Haripriya Gupta et al. Microorganisms
- Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
- (2019) Marta Flisiak-Jackiewicz et al. Advances in Medical Sciences
- Editorial: The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis due to NASH
- (2019) Rohit Loomba et al. HEPATOLOGY
- NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
- (2019) Ming-Feng Xia et al. Frontiers in Pharmacology
- Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
- (2019) Kazuki Takakura et al. Frontiers in Oncology
- Thiazolidinediones: the Forgotten Diabetes Medications
- (2019) Harold E. Lebovitz Current Diabetes Reports
- GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome
- (2019) Kadri Seppa et al. Scientific Reports
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- The Latest Insights into Adipokines in Diabetes
- (2019) Won Kon Kim et al. Journal of Clinical Medicine
- Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes
- (2019) Eun Shil Hong et al. BMJ Open Diabetes Research & Care
- Mitochondrial Dysfunction in the Transition from NASH to HCC
- (2019) Mélissa Léveillé et al. Metabolites
- Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
- (2019) Maria Nicoline Baandrup Kristiansen et al. BMC GASTROENTEROLOGY
- Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design
- (2019) Quentin M. Anstee et al. Contemporary Clinical Trials
- Increased liver localization of lipopolysaccharides in human and experimental non‐alcoholic fatty liver disease
- (2019) Guido Carpino et al. HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis
- (2018) B. Hameed et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans
- (2018) Andreas Peter et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Does Nox2 over-activate in children with non-alcoholic fatty liver disease?
- (2018) Lorenzo Loffredo et al. ANTIOXIDANTS & REDOX SIGNALING
- Human plasma retinol-binding protein (RBP4) is also a fatty acid-binding protein
- (2018) Massimiliano Perduca et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism
- (2018) Graeme I. Lancaster et al. Cell Metabolism
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
- (2018) David Højland Ipsen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Reactive Oxygen Species in Metabolic and Inflammatory Signaling
- (2018) Steven J. Forrester et al. CIRCULATION RESEARCH
- Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
- (2018) Fernando Bril et al. Clinical Gastroenterology and Hepatology
- Dietary carbohydrates and fatty liver disease
- (2018) Sally Chiu et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor–Expressing Glutamatergic Neurons
- (2018) Jessica M. Adams et al. DIABETES
- Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis
- (2018) Frank Tacke EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
- (2018) Stephen A. Harrison et al. GASTROENTEROLOGY
- Hepatocellular Carcinoma-associated Protein TD26 Interacts and Enhances SREBP1 Activity to Promote Tumor Cell Proliferation and Growth
- (2018) Chenchen Wang et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Mitochondria in non-alcoholic fatty liver disease
- (2018) Inês C.M. Simões et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Accelerated inflammation and oxidative stress induced by LPS in acute lung injury: Ιnhibition by ST1926
- (2018) Zewu Dong et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis
- (2018) Katerina Kapodistria et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice
- (2018) Albert G. Linden et al. JOURNAL OF LIPID RESEARCH
- Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle
- (2018) Tae Woo Jung et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
- (2018) Kirstine S Tølbøl et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
- (2018) Yan-Lan Fang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis
- (2018) Byeong-Moo Kim et al. Scientific Reports
- Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
- (2018) Raffaella Gentilella et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease
- (2018) Andrew J. Muir et al. HEPATOLOGY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
- (2017) Na Jiao et al. GUT
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- ANGPTL8 (Betatrophin) is Expressed in Visceral Adipose Tissue and Relates to Human Hepatic Steatosis in Two Independent Clinical Collectives
- (2017) Christian von Loeffelholz et al. HORMONE AND METABOLIC RESEARCH
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice
- (2017) Cheng Jun Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The epidemiology of non-alcoholic fatty liver disease
- (2017) Stefano Bellentani LIVER INTERNATIONAL
- Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
- (2017) Pi-Xiao Wang et al. NATURE MEDICINE
- The Role of the Lysyl Oxidases in Tissue Repair and Remodeling: A Concise Review
- (2017) Linyi Cai et al. Tissue Engineering and Regenerative Medicine
- Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies
- (2017) Nishanth E. Sunny et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4–MD2 complex
- (2017) So Yeon Kim et al. Nature Communications
- Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
- (2017) Junli Ma et al. Nutrients
- Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2017) Ali Saeed et al. Nutrients
- Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population
- (2017) Zhengsen Cui et al. Oncotarget
- Lack of Adipocyte-Fndc5/Irisin Expression and Secretion Reduces Thermogenesis and Enhances Adipogenesis
- (2017) D. Pérez-Sotelo et al. Scientific Reports
- Increased Serum ANGPTL8 Concentrations in Patients with Prediabetes and Type 2 Diabetes
- (2017) Yanhua Yin et al. Journal of Diabetes Research
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- The Role of the Lysyl Oxidases in Tissue Repair and Remodeling: A Concise Review
- (2017) Linyi Cai et al. Tissue Engineering and Regenerative Medicine
- ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase
- (2017) Xun Chi et al. Molecular Metabolism
- Circulating Betatrophin Levels and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2017) Fei-Juan Kong et al. PLoS One
- Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation
- (2016) JING SHEN et al. ANTICANCER RESEARCH
- GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway
- (2016) Qin He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma
- (2016) Mohammed M.H. Al-Gayyar et al. BIOLOGICAL CHEMISTRY
- LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial
- (2016) L. Masmiquel et al. Cardiovascular Diabetology
- Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
- (2016) Cynthia Ju et al. Cellular & Molecular Immunology
- The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases
- (2016) Li Li et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design
- (2016) Scott Friedman et al. Contemporary Clinical Trials
- Regulation of lipid metabolism by angiopoietin-like proteins
- (2016) Wieneke Dijk et al. CURRENT OPINION IN LIPIDOLOGY
- A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes
- (2016) Hung-Tsung Wu et al. DIABETOLOGIA
- Innate Immunity and Inflammation in NAFLD/NASH
- (2016) Marco Arrese et al. DIGESTIVE DISEASES AND SCIENCES
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice
- (2016) Qi Gong et al. HEPATOLOGY
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- (2016) Fabio Piscaglia et al. HEPATOLOGY
- Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells
- (2016) Renxiong Wei et al. IMMUNOLOGY AND CELL BIOLOGY
- The Natural Course of Non-Alcoholic Fatty Liver Disease
- (2016) Luis Calzadilla Bertot et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reduction of Liver Steatosis and Fibrosis with an Ask1 Inhibitor in a Murine Model of Nash is Accompanied by Improvements in Cholesterol, Bile Acid and Lipid Metabolism
- (2016) G. Budas et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease
- (2016) C. von Loeffelholz et al. JOURNAL OF INVESTIGATIVE SURGERY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines
- (2016) Raika Jamali et al. MEDICINE
- Thiazolidinediones for nonalcoholic steatohepatitis
- (2016) Lingling He et al. MEDICINE
- Non-alcoholic fatty liver disease and diabetes
- (2016) Jonathan M. Hazlehurst et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- The Role of Cholesterol in the Pathogenesis of NASH
- (2016) George N. Ioannou TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease
- (2016) Raika Jamali et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma
- (2016) Yan Li et al. Oncotarget
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
- (2016) Ren Zhang Open Biology
- Microbial regulation of GLP-1 and L-cell biology
- (2016) Thomas U. Greiner et al. Molecular Metabolism
- Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase
- (2016) Nikolaos Stefanou et al. BMC CANCER
- Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies
- (2016) Yong-ho Lee et al. Scientific Reports
- Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice
- (2016) Fenni Rusli et al. Scientific Reports
- Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise
- (2015) Svenia Schnyder et al. BONE
- Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism
- (2015) Ruth C. Meex et al. Cell Metabolism
- Ghrelin Attenuated Lipotoxicity via Autophagy Induction and Nuclear Factor-κB Inhibition
- (2015) Yuqing Mao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs Population
- (2015) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2015) Stergios A. Polyzos et al. DIABETOLOGIA
- Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice
- (2015) Aaron R. Cox et al. DIABETOLOGIA
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Irisin: A true, circulating hormone
- (2015) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Leptin in nonalcoholic fatty liver disease: A narrative review
- (2015) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Liraglutide: A New Option for the Treatment of Obesity
- (2015) Wesley A. Nuffer et al. PHARMACOTHERAPY
- Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease
- (2015) Shao-Ren Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatic Steatosis as a Marker of Metabolic Dysfunction
- (2015) Elisa Fabbrini et al. Nutrients
- The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
- (2015) James Crane et al. Therapeutic Advances in Chronic Disease
- Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
- (2015) Mei Yang et al. PLoS One
- Revisiting PPARγ as a target for the treatment of metabolic disorders
- (2014) Sun-Sil Choi et al. BMB Reports
- NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease
- (2014) Maria Del Ben et al. BMC GASTROENTEROLOGY
- ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
- (2014) Hayato Nakagawa et al. CANCER CELL
- ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion
- (2014) Viktoria Gusarova et al. CELL
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- Liraglutide Enhances Insulin Sensitivity by Activating AMP-Activated Protein Kinase in Male Wistar Rats
- (2014) Satoru Yamazaki et al. ENDOCRINOLOGY
- Roles for Chemokines in Liver Disease
- (2014) Fabio Marra et al. GASTROENTEROLOGY
- Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer
- (2014) Krasimira Aleksandrova et al. HEPATOLOGY
- Management of hepatocellular carcinoma
- (2014) P. Fitzmorris et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects
- (2014) Motoya Sato et al. LIVER INTERNATIONAL
- Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
- (2014) Kevin Tak-Pan Ng et al. Molecular Cancer
- Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients
- (2014) Abby B. Siegel et al. ONCOLOGY
- LPS-induced oxidative stress and inflammatory reaction in the rat striatum
- (2014) Karolina Noworyta-Sokołowska et al. Pharmacological Reports
- Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
- (2014) Akinobu Ochi et al. PLoS One
- LPS promotes epithelial–mesenchymal transition and activation of TLR4/JNK signaling
- (2014) Hangyu Li et al. TUMOR BIOLOGY
- Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
- (2013) Theodore Kelesidis ANNALS OF INTERNAL MEDICINE
- Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
- (2013) Chaofeng Yang et al. BMC GASTROENTEROLOGY
- Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients
- (2013) Alisan Kahraman et al. CLINICAL SCIENCE
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling
- (2013) Y. Zhang et al. DIABETES
- Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
- (2013) G. Schernthaner et al. DIABETES CARE
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- Expression of Fibroblast Growth Factor 19 Is Associated with Recurrence and Poor Prognosis of Hepatocellular Carcinoma
- (2013) Jiyeon Hyeon et al. DIGESTIVE DISEASES AND SCIENCES
- Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults
- (2013) Ilhan Satman et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice
- (2013) Tiangang Li et al. HEPATOLOGY
- Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease
- (2013) Karima Begriche et al. HEPATOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis
- (2013) Lars P. Bechmann et al. HEPATOLOGY
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
- (2013) Robert J. Wong et al. HEPATOLOGY
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
- (2013) Yuki Kawano et al. JOURNAL OF GASTROENTEROLOGY
- The role of Hepassocin in the development of non-alcoholic fatty liver disease
- (2013) Hung-Tsung Wu et al. JOURNAL OF HEPATOLOGY
- Irisin in patients with nonalcoholic fatty liver disease
- (2013) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of hepatokines in metabolism
- (2013) Norbert Stefan et al. Nature Reviews Endocrinology
- Klotho Endows Hepatoma Cells with Resistance to Anoikis via VEGFR2/PAK1 Activation in Hepatocellular Carcinoma
- (2013) Lin Chen et al. PLoS One
- Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization
- (2013) Valeriy Demchev et al. PLoS One
- The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis
- (2013) Fatma Ucar et al. REDOX REPORT
- Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity
- (2013) Cesar Corzo et al. Diabetes & Metabolism Journal
- Liver cholesterol: is it playing possum in NASH?
- (2012) Geoffrey C. Farrell et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
- (2012) Seiki Miura et al. BMC CANCER
- Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide
- (2012) Ying-Ying Jing et al. BMC Medicine
- Urinary biomarkers of oxidative status
- (2012) Dora Il'yasova et al. CLINICA CHIMICA ACTA
- Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
- (2012) Konstantinos Tziomalos et al. Current Vascular Pharmacology
- GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence
- (2012) A. R. Meloni et al. DIABETES OBESITY & METABOLISM
- Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
- (2012) Luciano Adorini et al. DRUG DISCOVERY TODAY
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease
- (2012) Lorenzo Loffredo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Obesity and Hypercholesterolemia are Associated with NOX2 Generated Oxidative Stress and Arterial Dysfunction
- (2012) Lorenzo Loffredo et al. JOURNAL OF PEDIATRICS
- Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
- (2012) Durba Pal et al. NATURE MEDICINE
- The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
- (2012) Takamasa Ohki et al. TheScientificWorldJOURNAL
- Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
- (2011) Jamie E. Mells et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis
- (2011) Salvatore Petta et al. DIGESTIVE AND LIVER DISEASE
- Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome
- (2011) Francesco Angelico et al. Internal and Emergency Medicine
- DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
- (2011) Erwin Gäbele et al. JOURNAL OF HEPATOLOGY
- The interaction of hepatic lipid and glucose metabolism in liver diseases
- (2011) Lars P. Bechmann et al. JOURNAL OF HEPATOLOGY
- FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways
- (2011) Ai-Luen Wu et al. PLoS One
- Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
- (2011) Hongmei Yan et al. PLoS One
- Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis
- (2010) M. O. Rakoski et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance
- (2010) Suman Dasgupta et al. BIOCHEMICAL JOURNAL
- Crosstalk of reactive oxygen species and NF-κB signaling
- (2010) Michael J Morgan et al. CELL RESEARCH
- Vitamin E and C supplementation reduces oxidative stress, improves antioxidant enzymes and positive muscle work in chronically loaded muscles of aged rats
- (2010) Michael J. Ryan et al. EXPERIMENTAL GERONTOLOGY
- Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma
- (2010) Neeraj K. Saxena et al. GASTROENTEROLOGY
- Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis
- (2010) Dipali Sharma et al. HEPATOLOGY
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
- (2010) G A Garinis et al. INTERNATIONAL JOURNAL OF OBESITY
- Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor
- (2010) Hector M. Rodriguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Elevated endotoxin levels in non-alcoholic fatty liver disease
- (2010) Alison L Harte et al. Journal of Inflammation-London
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modern sedentary activities promote overconsumption of food in our current obesogenic environment
- (2010) J.-P. Chaput et al. Obesity Reviews
- Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome
- (2010) Teresa Coll et al. Current Molecular Pharmacology
- PPARδ in humans: genetic and pharmacological evidence for a significant metabolic function
- (2009) Fredrik Karpe et al. CURRENT OPINION IN LIPIDOLOGY
- Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis
- (2009) L. Serfaty et al. DIABETES & METABOLISM
- Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure
- (2009) C. Y. Li et al. GUT
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Specific Expression and Regulation of Hepassocin in the Liver and Down-regulation of the Correlation of HNF1α with Decreased Levels of Hepassocin in Human Hepatocellular Carcinoma
- (2009) Hai-Tao Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serum Retinol-binding Protein 4 Levels in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Naim Alkhouri et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model
- (2009) Hiroshi Kudo et al. JOURNAL OF HEPATOLOGY
- Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism
- (2009) Phyllis P. Sun et al. KIDNEY INTERNATIONAL
- Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis
- (2009) Maria Luisa Balmer et al. LIVER INTERNATIONAL
- Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus
- (2009) Nikolaos P.E. Kadoglou et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis
- (2008) Matthias J. Bahr et al. CLINICAL ENDOCRINOLOGY
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus
- (2008) Gokhan Erdem et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Mechanisms of Hepatic Fibrogenesis
- (2008) Scott L. Friedman GASTROENTEROLOGY
- Olmesartan Prevents Cardiovascular Injury and Hepatic Steatosis in Obesity and Diabetes, Accompanied by Apoptosis Signal Regulating Kinase-1 Inhibition
- (2008) Eiichiro Yamamoto et al. HYPERTENSION
- Effects of Pretreatment with Low-dose Metformin on Metabolic Parameters and Weight Gain by Pioglitazone in Japanese Patients with Type 2 Diabetes
- (2008) Toshihide Kawai et al. INTERNAL MEDICINE
- Chylomicrons promote intestinal absorption of lipopolysaccharides
- (2008) Sarbani Ghoshal et al. JOURNAL OF LIPID RESEARCH
- Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus
- (2008) Katsuhito Mori et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease
- (2007) J. A. Seo et al. CLINICAL ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started